Prescription drug · ANDA
Caffeine Citrate NDC 42571-346
Caffeine citrate 60 mg/3mL · Solution · Oral · Micro Labs Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42571-346-69 | 4257103466942571034669 | 10 VIAL in 1 BOX (42571-346-69) / 3 mL in 1 VIALMarketed from Feb 1, 2020 | |
| 42571-346-96 | 4257103469642571034696 | 5 VIAL in 1 BOX (42571-346-96) / 3 mL in 1 VIALMarketed from Apr 23, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Caffeine Citrate
- Generic name (nonproprietary)
- caffeine citrate
- Active ingredients
- Caffeine citrate — 60 mg/3mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Micro Labs LimitedNDC labeler code 42571
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213202
- Marketing start
- Listing expires
- Other FDA classes
- Central Nervous System Stimulation (Physiologic effect)Xanthines (Chemical structure)
- Identifiers
- Product ID 42571-346_57f8cddb-4aa6-756c-e063-6394a90ad218SPL ID 57f8cddb-4aa6-756c-e063-6394a90ad218SPL set ID db4477a3-b291-4b77-9eca-b7ba8f66b2beRxCUI 849928UNII U26EO4675QUPC 0342571346690
- Pharmacologic class
- Central Nervous System Stimulant; Methylxanthine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442571034669followed by a unit qualifier and the quantityPackage 42571-0346-69. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Caffeine citrate is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age.
Excerpt only. Read the full label for complete information.
About NDC 42571-346
- What is NDC 42571-346?
- 42571-346 is the product NDC for Caffeine Citrate, Caffeine citrate 60 mg/3mL solution, listed with the FDA by Micro Labs Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Caffeine Citrate.
- What is the active ingredient?
- Caffeine citrate.
- Who is the labeler?
- Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Caffeine Citrate?
- 12 other product NDCs are listed under this name. See all Caffeine Citrate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Caffeine Citrate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Caffeine Citrate | Caffeine citrate 20 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0641-6267 | 00641-6267-10 |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | SolutionOral | Sun Pharmaceutical Industries, Inc. | 47335-290 | 47335-0290-44 |
| Caffeine Citrate | Caffeine citrate 60 mg/3mL | InjectionIntravenous | Armas Pharmaceuticals Inc. | 72485-104 | 72485-0104-0172485-0104-10 |
| Caffeine Citrate | Caffeine citrate 60 mg/3mL | Injection, SolutionIntramuscular, Intravenous | Micro Labs Limited | 42571-244 | 42571-0244-98 |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-187 | 55150-0187-03 |
| caffeine citrate | Caffeine citrate 20 mg/mL | InjectionIntravenous | Exela Pharma Sciences, LLC | 51754-0500 | 51754-0500-01 |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | InjectionIntravenous | Sun Pharmaceutical Industries, Inc. | 47335-289 | 47335-0289-27 |
| caffeine citrate | Caffeine citrate 20 mg/mL | SolutionIntravenous | Sagent Pharmaceuticals | 25021-601 | 25021-0601-03 |
| caffeine citrate | Caffeine citrate 20 mg/mL | SolutionOral | Sagent Pharmaceuticals | 25021-602 | 25021-0602-03 |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | SolutionOral | Fresenius Kabi USA, LLC | 63323-406 | 63323-0406-03 |
Other NDCs under ANDA 213202
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Caffeine Citrate Oral Solutioncaffeine citrate | Caffeine citrate 60 mg/3mL | SolutionOral | Armas Pharmaceuticals Inc. | 72485-110 |